The nation of Zimbabwe has turned down a significant American healthcare agreement valued at 367 million US dollars (£272m) over five years because of Washington's demand for sensitive data.
The decision was revealed after a government memo from December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
A government spokesman has since stated that the US was seeking biological samples for research and commercial gain while refused to guarantee the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for continued negotiations to find a agreement acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.
Broader Background
This rejection comes after a similar case in Kenya, where a high court halted a related health funding agreement following concerns were raised about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government agreements to boost openness and responsibility.
According to reports, Sixteen nations in Africa have so far signed these new agreements, representing over $18.3bn in committed funds.
Details of the Rejected Deal
The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership might have yielded extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to provide its genetic material and health information for a long time, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that might result from that shared data," he stated.
"Effectively, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our population should a new pandemic emerge."
Sovereignty and Global Health
He also said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending frameworks previously set up through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to deal with future global health emergencies.
"This mechanism is designed to ensure that when a country provides its data, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."
The government's concerns over the US deal "are not meant as opposition to America," Mangwana stressed.
"We welcome further dialogue with our US partners on how subsequent collaboration might be structured in a manner that honours the sovereignty and interests of both nations."
Medical Community Response
A leading public health body stated it acknowledged the government's concerns, but recommended that talks need to persist since a large portion of the nation's Aids initiatives depended on foreign aid.
"In cases where technical issues arise, such as those involving information security or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it added.
This impasse emphasises the continuing challenges between receiving much-needed foreign assistance and protecting local interests in an ever more data-driven world.